Measurement of the Oct4 level in tumor tissue by western blotting and immunohistochemistry showed that Oct4 expression was significantly suppressed in the mouse model of breast cancer using stable JMJD3-overexpressing cells compared with the control, which was accompanied by a lower expression level of ALDH (Figure 2E, 2F). The gene discussed is POU5F1; the disease is neoplasm.